Surfactant-derived proteins as markers of alveolar membrane damage in heart failure.

Surfactant-derived proteins as markers of alveolar membrane damage in heart failure.

In heart failure (HF) alveolar-capillary membrane is abnormal. Surfactant-derived proteins (SPs) and plasma receptor for advanced-glycation-end-products (RAGE) have been proposed as lung damage markers.Eighty-nine chronic HF and 17 healthy subjects were evaluated by echocardiography, blood parameter...

Full description

Bibliographic Details
Main Authors:	Paola Gargiulo, Cristina Banfi, Stefania Ghilardi, Damiano Magrì, Marta Giovannardi, Alice Bonomi, Elisabetta Salvioni, Elisa Battaia, Pasquale Perrone Filardi, Elena Tremoli, Piergiuseppe Agostoni
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4267772?pdf=render

Similar Items

Editorial: Exercise and heart failure
by: Elisabetta Salvioni, et al.
Published: (2022-09-01)

Impact of Sacubitril/Valsartan on surfactant binding proteins, central sleep apneas, lung function tests and heart failure biomarkers: Hemodynamic or pleiotropism?
by: Massimo Mapelli, et al.
Published: (2022-09-01)

A non invasive estimate of dead space ventilation from exercise measurements.
by: Paola Gargiulo, et al.
Published: (2014-01-01)

Symptomatic post COVID patients have impaired alveolar capillary membrane function and high VE/VCO2
by: Piergiuseppe Agostoni, et al.
Published: (2024-02-01)

Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways
by: Massimo Mapelli, et al.
Published: (2023-09-01)

Editorial: Cardiac reverse remodeling after novel heart failure therapies
by: Massimo Mapelli, et al.
Published: (2024-02-01)

Impact of Sacubitril/Valsartan on Circulating microRNA in Patients with Heart Failure
by: Maura Brioschi, et al.
Published: (2023-03-01)

Redox proteomics identification of oxidatively modified myocardial proteins in human heart failure: implications for protein function.
by: Maura Brioschi, et al.
Published: (2012-01-01)

Role of alveolar β2-adrenergic receptors on lung fluid clearance and exercise ventilation in healthy humans.
by: Stefania Paolillo, et al.
Published: (2013-01-01)

“Under the Bridge”: Looking for Ischemia in a Patient with Intramyocardial Coronary Artery Course—The Role of the Cardiopulmonary Exercise Test
by: Massimo Mapelli, et al.
Published: (2023-09-01)

The role of cardiopulmonary exercise tests in pulmonary arterial hypertension
by: Stefania Farina, et al.
Published: (2018-05-01)

Cardiac output changes during exercise in heart failure patients: focus on mid‐exercise
by: Nicoletta Corrieri, et al.
Published: (2021-02-01)

Immature Circulating SP-B, Bound to HDL, Represents an Early Sign of Smoke-Induced Pathophysiological Alterations
by: Cristina Banfi, et al.
Published: (2021-04-01)

Brisk walking can be a maximal effort in heart failure patients: a comparison of cardiopulmonary exercise and 6 min walking test cardiorespiratory data
by: Massimo Mapelli, et al.
Published: (2022-04-01)

Minute ventilation/carbon dioxide production in chronic heart failure
by: Piergiuseppe Agostoni, et al.
Published: (2021-02-01)

Taking a walk on the heart failure side: comparison of metabolic variables during walking and maximal exertion
by: Massimo Mapelli, et al.
Published: (2024-04-01)

On Top of the Alveolar Epithelium: Surfactant and the Glycocalyx
by: Matthias Ochs, et al.
Published: (2020-04-01)

Multiplexed MRM-Based Proteomics Identified Multiple Biomarkers of Disease Severity in Human Heart Failure
by: Maura Brioschi, et al.
Published: (2021-01-01)

Case Report: Acute Heart Failure Induced by the Combination of Takayasu's, Takotsubo and Coronary Vasospasm in an Elementary School Teacher–A Reaction to Return-to-Work Stress After COVID-19?
by: Inês Pires, et al.
Published: (2022-05-01)

Airway allergy causes alveolar macrophage death, profound alveolar disorganization and surfactant dysfunction
by: Lidia Feo-Lucas, et al.
Published: (2023-05-01)

β-Blockers and Erectile Dysfunction in Heart Failure. Between Myth and Reality
by: Sara Corradetti, et al.
Published: (2022-05-01)

Intrapulmonary distribution of blood flow during exercise in pulmonary hypertension assessed by a new combination technique
by: Stefania Farina, et al.
Published: (2023-09-01)

Cardiac Reverse Remodelling by 2D and 3D Echocardiography in Heart Failure Patients Treated with Sacubitril/Valsartan
by: Valentina Mantegazza, et al.
Published: (2021-10-01)

Macrophage Phenotyping in Atherosclerosis by Proteomics
by: Sonia Eligini, et al.
Published: (2023-01-01)

Targeted PPARγ deficiency in alveolar macrophages disrupts surfactant catabolism
by: Anna D. Baker, et al.
Published: (2010-06-01)

Data for proteomic analysis of murine cardiomyocytic HL-1 cells treated with siRNA against tissue factor
by: Maura Brioschi, et al.
Published: (2015-06-01)

Corrigendum to “Data for proteomic analysis of murine cardiomyocytic HL-1 cells treated with siRNA against tissue factor” [Data Brief 3 (2015) 117–119]
by: Maura Brioschi, et al.
Published: (2015-12-01)

<i>N</i>-Acetyl-Cysteine Regenerates Albumin Cys34 by a Thiol-Disulfide Breaking Mechanism: An Explanation of Its Extracellular Antioxidant Activity
by: Alessandra Altomare, et al.
Published: (2020-04-01)

Estimating maximum work rate during cardiopulmonary exercise testing from the six-minute walk distance in patients with heart failure
by: Giancarlo Piaggi, et al.
Published: (2024-06-01)

Two is better than one: the double diffusion technique in classifying heart failure
by: Gerald S. Zavorsky, et al.
Published: (2024-01-01)

The Current Role of Cardiopulmonary Exercise Test in the Diagnosis and Management of Pulmonary Hypertension
by: Beatrice Pezzuto, et al.
Published: (2023-08-01)

Exertional dyspnoea in cardiorespiratory disorders: the clinical use of cardiopulmonary exercise testing
by: Pierantonio Laveneziana, et al.
Published: (2016-09-01)

Eustachian tube surfactant is different from alveolar surfactant: determination of phospholipid composition of porcine eustachian tube lavage fluid
by: Reija Paananen, et al.
Published: (2002-01-01)

Rest and exercise oxygen uptake and cardiac output changes 6 months after successful transcatheter mitral valve repair
by: Carlo Vignati, et al.
Published: (2021-12-01)

Is red distribution width a valid tool to predict impaired iron transport in heart failure?
by: Jeness Campodonico, et al.
Published: (2023-04-01)

Aortic thrombosis: the forgotten source of ischemic stroke. A case report and systematic review of the literature
by: Christian Basile, et al.
Published: (2021-12-01)

Prognostic Impact of Percutaneous Coronary Intervention in Chronic Dialysis Patients with Acute Myocardial Infarction: Findings from the Lombardy Health Database
by: Nicola Cosentino, et al.
Published: (2023-04-01)

Albumin Thiolation and Oxidative Stress Status in Patients with Aortic Valve Stenosis
by: Carlo Savini, et al.
Published: (2023-11-01)

Alveolar Dynamics and Beyond – The Importance of Surfactant Protein C and Cholesterol in Lung Homeostasis and Fibrosis
by: Kirsten Sehlmeyer, et al.
Published: (2020-05-01)

Signaling Pathways That Mediate Alveolar Macrophage Activation by Surfactant Protein A and IL-4
by: Belén García-Fojeda, et al.
Published: (2022-04-01)